FORTIS - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 2.9
| Stock Code | FORTIS | Market Cap | 71,695 Cr. | Current Price | 950 ₹ | High / Low | 1,105 ₹ |
| Stock P/E | 411 | Book Value | 122 ₹ | Dividend Yield | 0.11 % | ROCE | 3.27 % |
| ROE | 1.41 % | Face Value | 10.0 ₹ | DMA 50 | 887 ₹ | DMA 200 | 869 ₹ |
| Chg in FII Hold | -1.86 % | Chg in DII Hold | 2.02 % | PAT Qtr | 24.7 Cr. | PAT Prev Qtr | 105 Cr. |
| RSI | 65.8 | MACD | 25.7 | Volume | 9,57,385 | Avg Vol 1Wk | 11,01,253 |
| Low price | 623 ₹ | High price | 1,105 ₹ | PEG Ratio | 2.61 | Debt to equity | 0.22 |
| 52w Index | 67.7 % | Qtr Profit Var | -30.0 % | EPS | 2.16 ₹ | Industry PE | 48.0 |
📊 FORTIS shows weak fundamentals and is not a strong candidate for long-term investment at present. ROE (1.41%) and ROCE (3.27%) are very low, indicating poor efficiency. The P/E ratio (411) is extremely high compared to the industry average (48.0), suggesting severe overvaluation. Dividend yield (0.11%) is negligible, reducing investor appeal. EPS of ₹2.16 is very weak relative to price, and PEG ratio (2.61) indicates valuations are stretched relative to growth. Recent PAT decline (₹24.7 Cr vs ₹105 Cr) further weakens the outlook despite technical momentum showing short-term strength.
💡 Ideal Entry Price Zone: Accumulation is only advisable near ₹850–₹880, close to DMA support. Current price of ₹950 is not attractive given weak fundamentals and high risk.
⏳ Exit Strategy / Holding Period: If already holding, consider exiting on rallies near ₹1,000–₹1,050 unless profitability improves significantly. Long-term holding is not recommended until ROE, ROCE, and earnings show sustained improvement.
✅ Positive
- Large market cap (₹71,695 Cr) provides scale and visibility.
- DII holdings increased (+2.02%), showing domestic institutional support.
- Stock trading above 50 DMA and 200 DMA, showing near-term technical strength.
⚠️ Limitation
- Extremely high P/E (411) compared to industry average (48.0).
- Weak ROE (1.41%) and ROCE (3.27%).
- Dividend yield (0.11%) is negligible.
- EPS of ₹2.16 is very low relative to price.
📉 Company Negative News
- Quarterly PAT declined sharply (₹24.7 Cr vs ₹105 Cr).
- Quarterly profit variation (-30%) shows earnings volatility.
- Decline in FII holdings (-1.86%), showing reduced foreign investor confidence.
📈 Company Positive News
- DII holdings increased (+2.02%), reflecting domestic institutional support.
- MACD and RSI indicate bullish technical momentum in the short term.
🏭 Industry
- Industry PE (48.0) is much lower than company PE, suggesting FORTIS trades at a steep premium.
- Healthcare sector benefits from rising demand and government support, but profitability remains key.
🔎 Conclusion
FORTIS is not a strong candidate for long-term investment at present due to weak efficiency metrics, poor earnings, and extreme valuations. Investors should avoid fresh entry until fundamentals improve. Existing holders may consider exiting on rallies near ₹1,000–₹1,050 unless profitability strengthens significantly.